Kevin Maloy

Kevin Maloy is an experienced healthcare executive with a strong background in patient access and reimbursement strategies. Currently serving as Executive Director and Head of Field Reimbursement at BridgeBio since October 2023, Kevin previously held various leadership roles at Neurocrine Biosciences, including Executive Director of Patient Access and Director of Patient Access. At Vanda Pharmaceuticals, Kevin successfully implemented HUB services for the launch of Hetlioz®, achieving and exceeding sales goals. Prior experience includes leadership at Acorda Therapeutics, where Kevin directed national reimbursement assistance and managed a team supporting specialty products. Kevin's career also includes roles at i3 Pharma Informatics, Schering-Plough, and Pfizer. Kevin holds a BA in Management from Gettysburg College.